Subscribe to RSS

DOI: 10.1055/s-0045-1809625
Comparison of the Risk of Early Postoperative Infection and Length of Hospital Stay between Sarcopenic and Nonsarcopenic Adults Undergoing Live Donor Liver Transplantation Using Computed Tomography
Authors
Abstract
Objectives
Computed tomography (CT)-based sarcopenia assessment and the risk of early postoperative infection among adults undergoing live donor liver transplantation.
This article also compares the postoperative length of hospital stay in sarcopenic and nonsarcopenic patients after live donor liver transplantation.
Materials and Methods
Sixty live donor liver transplantation recipients undergoing abdominal CT scans were included during the period from April 2022 to February 2024. CT data was obtained via 128-slice Revolution Frontier CT by GE Healthcare. Individual vertebral levels were identified on CT scan and skeletal muscle cross-sectional areas were computed using MATLAB algorithms. SliceOmatic software aided in muscle area determination and L3 vertebra served as the reference for assessing abdominal muscles. Skeletal muscle index was derived by normalizing muscle area to height. Sex-specific sarcopenia cutoffs were applied based on CT findings. Postoperative care included surveillance for infections using blood culture positivity.
Results
Note that 76.47% of the infected patients were sarcopenic while 23.53% were nonsarcopenic. Also, 32.56% of the noninfected patients were sarcopenic whereas 67.44% were nonsarcopenic (p-value = 0.003). Postop length of hospital stay in days showed a significant difference between the two groups (p ≤ 0.001), with the sarcopenic group having the greatest median postop length of hospital stay.
Conclusion
Pretransplant sarcopenia as determined by skeletal muscle index is associated with an increased risk of posttransplant infections in a group of patients undergoing liver transplantation as well as longer stay in hospital.
Keywords
computed tomography - infection - live donor liver transplantation - liver transplantation - skeletal muscle area - skeletal muscle indexEthical Approval
The study was performed conforming to the Helsinki Declaration of 1975, as revised in 2000 and 2008 concerning human and animal rights, and the authors followed the policy concerning informed consent as shown on Springer.com.
Patients' Consent
Informed patient consent was taken from the study subjects to enroll them in the study.
Publication History
Article published online:
11 June 2025
© 2025. Indian Radiological Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Dhaliwal A, Armstrong MJ. Sarcopenia in cirrhosis: a practical overview. Clin Med (Lond) 2020; 20 (05) 489-492
- 2 Brown S, Richardson B, Bouquet E. et al. Cirrhosis-related sarcopenia may not resolve after liver transplantation. JHEP Rep Innov Hepatol 2023; 5 (11) 100881
- 3 Krell RW, Kaul DR, Martin AR. et al. Association between sarcopenia and the risk of serious infection among adults undergoing liver transplantation. Liver Transpl 2013; 19 (12) 1396-1402
- 4 Sinclair M, Gow PJ, Grossmann M, Angus PW. Review article: sarcopenia in cirrhosis–aetiology, implications and potential therapeutic interventions. Aliment Pharmacol Ther 2016; 43 (07) 765-777
- 5 Montano-Loza AJ, Meza-Junco J, Baracos VE. et al. Severe muscle depletion predicts postoperative length of stay but is not associated with survival after liver transplantation. Liver Transpl 2014; 20 (06) 640-648
- 6 Hernandez MdelP, Martin P, Simkins J. Infectious complications after liver transplantation. Gastroenterol Hepatol (N Y) 2015; 11 (11) 741-753
- 7 Uchiyama H. Sarcopenia in liver transplant recipients: its relevance to peritransplant morbidity and mortality. Hepatobiliary Surg Nutr 2017; 6 (03) 196-199
- 8 Anand A, Mohta S, Agarwal S. et al. European Working Group on Sarcopenia in Older People (EWGSOP2) criteria with population-based skeletal muscle index best predicts mortality in Asians with cirrhosis. J Clin Exp Hepatol 2022; 12 (01) 52-60

